-
1
-
-
84055193505
-
The economic cost of brain disorders in Europe
-
Olesen, J. et al. The economic cost of brain disorders in Europe. Eur. J. Neurol. 19, 155-162 (2012).
-
(2012)
Eur. J. Neurol
, vol.19
, pp. 155-162
-
-
Olesen, J.1
-
2
-
-
80555135824
-
The aging brain and neurodegenerative diseases
-
Duncan, G. W. The aging brain and neurodegenerative diseases. Clin. Geriatr. Med. 27, 629-644 (2011).
-
(2011)
Clin. Geriatr. Med
, vol.27
, pp. 629-644
-
-
Duncan, G.W.1
-
3
-
-
2542596183
-
Parkinson's disease
-
Samii, A., Nutt, J. G. & Ransom, B. R. Parkinson's disease. Lancet 363, 1783-1793 (2004).
-
(2004)
Lancet
, vol.363
, pp. 1783-1793
-
-
Samii, A.1
Nutt, J.G.2
Ransom, B.R.3
-
4
-
-
0025954066
-
Ageing and Parkinson's disease: Substantia nigra regional selectivity
-
Fearnley, J. M. & Lees, A. J. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 114, 2283-2301 (1991).
-
(1991)
Brain
, vol.114
, pp. 2283-2301
-
-
Fearnley, J.M.1
Lees, A.J.2
-
5
-
-
77955844658
-
Staging of serotonergic dysfunction in Parkinson's disease: An in vivo 11C-DASB PET study
-
Politis, M. et al. Staging of serotonergic dysfunction in Parkinson's disease: an in vivo 11C-DASB PET study. Neurobiol. Dis. 40, 216-221 (2010).
-
(2010)
Neurobiol. Dis
, vol.40
, pp. 216-221
-
-
Politis, M.1
-
6
-
-
84912079277
-
Serotonin in Parkinson's disease
-
Politis, M. & Niccolini, F. Serotonin in Parkinson's disease. Behav. Brain. Res. http://dx.doi.org/10.1016/j.bbr.2014.07.037.
-
Behav. Brain. Res
-
-
Politis, M.1
Niccolini, F.2
-
7
-
-
14744290753
-
Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned primate model of Parkinson's disease
-
Hallett, P. J. et al. Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned primate model of Parkinson's disease. Neuropharmacology 48, 503-516 (2005).
-
(2005)
Neuropharmacology
, vol.48
, pp. 503-516
-
-
Hallett, P.J.1
-
8
-
-
0030727688
-
Alterations in opioid receptor binding in Parkinson's disease patients with levodopa-induced dyskinesias
-
Piccini, P., Weeks, R. A. & Brooks, D. J. Alterations in opioid receptor binding in Parkinson's disease patients with levodopa-induced dyskinesias. Ann. Neurol. 42, 720-726 (1997).
-
(1997)
Ann. Neurol
, vol.42
, pp. 720-726
-
-
Piccini, P.1
Weeks, R.A.2
Brooks, D.J.3
-
9
-
-
20944435840
-
High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patients
-
Pisani, A. et al. High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patients. Ann. Neurol. 57, 777-779 (2005).
-
(2005)
Ann. Neurol
, vol.57
, pp. 777-779
-
-
Pisani, A.1
-
10
-
-
0033010467
-
Positron emission tomographic measurement of acetylcholinesterase activity reveals differential loss of ascending cholinergic systems in Parkinson's disease and progressive supranuclear palsy
-
Shinotoh, H. et al. Positron emission tomographic measurement of acetylcholinesterase activity reveals differential loss of ascending cholinergic systems in Parkinson's disease and progressive supranuclear palsy. Ann. Neurol. 46, 62-69 (1999).
-
(1999)
Ann. Neurol
, vol.46
, pp. 62-69
-
-
Shinotoh, H.1
-
11
-
-
77955782898
-
Parkinson's disease symptoms: The patient's perspective
-
Politis, M. et al. Parkinson's disease symptoms: the patient's perspective. Mov. Disord. 25, 1646-1651 (2010).
-
(2010)
Mov. Disord
, vol.25
, pp. 1646-1651
-
-
Politis, M.1
-
12
-
-
77953793084
-
-
(eds Clarke, C. et al.), Wiley-Blackwell
-
Clarke, C., Howard, R., Rossor, M. & Shorvon, S. D. in Neurology: A Queen Square Textbook (eds Clarke, C. et al.) 155-188 (Wiley-Blackwell, 2011).
-
(2011)
Neurology: A Queen Square Textbook
, pp. 155-188
-
-
Clarke, C.1
Howard, R.2
Rossor, M.3
Shorvon, S.D.4
-
13
-
-
84895853793
-
Dopamine receptor mapping with PET imaging in Parkinson's disease
-
Niccolini, F., Su, P. & Politis, M. Dopamine receptor mapping with PET imaging in Parkinson's disease. J. Neurol. http://dx.doi.org/10.1007/s00415-014-7302-2.
-
J. Neurol
-
-
Niccolini, F.1
Su, P.2
Politis, M.3
-
14
-
-
0032699176
-
Logistic discriminant parametric mapping: A novel method for the pixel-based differential diagnosis of Parkinson's disease
-
Acton, P. D., Mozley, P. D. & Kung, H. F. Logistic discriminant parametric mapping: a novel method for the pixel-based differential diagnosis of Parkinson's disease. Eur. J. Nucl. Med. 26, 1413-1423 (1999).
-
(1999)
Eur. J. Nucl. Med
, vol.26
, pp. 1413-1423
-
-
Acton, P.D.1
Mozley, P.D.2
Kung, H.F.3
-
15
-
-
0032217111
-
[123I] β-CIT and SPECT in essential tremor and Parkinson's disease
-
Asenbaum, S. et al. [123I]β-CIT and SPECT in essential tremor and Parkinson's disease. J. Neural Transm. 105, 1213-1228 (1998).
-
(1998)
J. Neural Transm
, vol.105
, pp. 1213-1228
-
-
Asenbaum, S.1
-
16
-
-
0034029152
-
Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: The [123I]-FP-CIT study group
-
Benamer, T. S. et al. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Mov. Disord. 15, 503-510 (2000).
-
(2000)
Mov. Disord
, vol.15
, pp. 503-510
-
-
Benamer, T.S.1
-
17
-
-
0034727597
-
A multicenter assessment of dopamine transporter imaging with DOPASCAN/SPECT in parkinsonism. Parkinson Study Group
-
[No authors listed]
-
[No authors listed] A multicenter assessment of dopamine transporter imaging with DOPASCAN/SPECT in parkinsonism. Parkinson Study Group. Neurology 55, 1540-1547 (2000).
-
(2000)
Neurology
, vol.55
, pp. 1540-1547
-
-
-
18
-
-
0141502274
-
Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: Part 1. Baseline and 3-month observations
-
Benamer, H. T. et al. Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: part 1. Baseline and 3-month observations. Mov. Disord. 18, 977-984 (2003).
-
(2003)
Mov. Disord
, vol.18
, pp. 977-984
-
-
Benamer, H.T.1
-
19
-
-
0034761293
-
Quantitative analysis of striatal dopamine D2 receptors with 123I-iodolisuride SPECT in degenerative extrapyramidal diseases
-
Prunier, C. et al. Quantitative analysis of striatal dopamine D2 receptors with 123I-iodolisuride SPECT in degenerative extrapyramidal diseases. Nucl. Med. Commun. 22, 1207-1214 (2001).
-
(2001)
Nucl. Med. Commun
, vol.22
, pp. 1207-1214
-
-
Prunier, C.1
-
20
-
-
0035526277
-
[123I] β-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy
-
Varrone, A. Marek, K. L., Jennings, D., Innis, R. B. & Seibyl, J. P. [123I]β-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy. Mov. Disord. 16, 1023-1032 (2001).
-
(2001)
Mov. Disord
, vol.16
, pp. 1023-1032
-
-
Varrone, A.1
Marek, K.L.2
Jennings, D.3
Innis, R.B.4
Seibyl, J.P.5
-
21
-
-
1842836514
-
Clinical impact of diagnostic SPET investigations with a dopamine re-uptake ligand
-
Løkkegaard, A., Werdelin, L. M. & Friberg, L. Clinical impact of diagnostic SPET investigations with a dopamine re-uptake ligand. Eur. J. Nucl. Med. Mol. Imaging 29, 1623-1629 (2002).
-
(2002)
Eur. J. Nucl. Med. Mol. Imaging
, vol.29
, pp. 1623-1629
-
-
Løkkegaard, A.1
Werdelin, L.M.2
Friberg, L.3
-
22
-
-
0036561553
-
[123I] β-CIT SPECT distinguishes vascular parkinsonism from Parkinson's disease
-
Gerschlager, W. et al. [123I]β-CIT SPECT distinguishes vascular parkinsonism from Parkinson's disease. Mov. Disord. 17, 518-523 (2002).
-
(2002)
Mov. Disord
, vol.17
, pp. 518-523
-
-
Gerschlager, W.1
-
23
-
-
84862186620
-
The relationship between cerebral vascular disease and parkinsonism: The VADO study
-
Antonini, A. et al. The relationship between cerebral vascular disease and parkinsonism: the VADO study. Parkinsonism Relat. Disord. 18, 775-780 (2012).
-
(2012)
Parkinsonism Relat. Disord
, vol.18
, pp. 775-780
-
-
Antonini, A.1
-
24
-
-
34548224682
-
[123I] FP-CIT SPECT study in vascular parkinsonism and Parkinson's disease
-
Zijlmans, J. et al. [123I] FP-CIT SPECT study in vascular parkinsonism and Parkinson's disease. Mov. Disord. 22, 1278-85 (2007).
-
(2007)
Mov. Disord
, vol.22
, pp. 1278-1285
-
-
Zijlmans, J.1
-
25
-
-
84872677723
-
Clinical features and 123I-FP-CIT SPECT imaging in vascular parkinsonism and Parkinson's disease
-
Benítez-Rivero, S. et al. Clinical features and 123I-FP-CIT SPECT imaging in vascular parkinsonism and Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 84, 122-129 (2013).
-
(2013)
J. Neurol. Neurosurg. Psychiatry
, vol.84
, pp. 122-129
-
-
Benítez-Rivero, S.1
-
26
-
-
0025864333
-
SPECT imaging of dopamine D2 receptors with 123I-IBZM: Initial experience in controls and patients with Parkinson's syndrome and Wilson's disease
-
Tatsch, K., Schwarz, J., Oertel, W. H. & Kirsch, C. M. SPECT imaging of dopamine D2 receptors with 123I-IBZM: initial experience in controls and patients with Parkinson's syndrome and Wilson's disease. Nucl. Med. Commun. 12, 699-707 (1991).
-
(1991)
Nucl. Med. Commun
, vol.12
, pp. 699-707
-
-
Tatsch, K.1
Schwarz, J.2
Oertel, W.H.3
Kirsch, C.M.4
-
27
-
-
0031594330
-
123I-IBZM binding compared with long-term clinical follow up in patients with de novo parkinsonism
-
Schwarz, J. et al. 123I-IBZM binding compared with long-term clinical follow up in patients with de novo parkinsonism. Mov. Disord. 13, 16-19 (1998).
-
(1998)
Mov. Disord
, vol.13
, pp. 16-19
-
-
Schwarz, J.1
-
28
-
-
17844398549
-
Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: Study on 72 patients
-
Plotkin, M. et al. Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patients. J. Neural Transm. 112, 677-692 (2005).
-
(2005)
J. Neural Transm
, vol.112
, pp. 677-692
-
-
Plotkin, M.1
-
29
-
-
34248999903
-
Does combined imaging of the pre- and postsynaptic dopaminergic system increase the diagnostic accuracy in the differential diagnosis of parkinsonism?
-
Koch, W., Hamann, C., Radau, P. E. & Tatsch, K. Does combined imaging of the pre- and postsynaptic dopaminergic system increase the diagnostic accuracy in the differential diagnosis of parkinsonism? Eur. J. Nucl. Med. Mol. Imaging 34, 1265-1273 (2007).
-
(2007)
Eur. J. Nucl. Med. Mol. Imaging
, vol.34
, pp. 1265-1273
-
-
Koch, W.1
Hamann, C.2
Radau, P.E.3
Tatsch, K.4
-
30
-
-
79955756270
-
Diagnostic accuracy of combined FP-CIT, IBZM, and MIBG scintigraphy in the differential diagnosis of degenerative parkinsonism: A multidimensional statistical approach
-
Südmeyer, M. et al. Diagnostic accuracy of combined FP-CIT, IBZM, and MIBG scintigraphy in the differential diagnosis of degenerative parkinsonism: a multidimensional statistical approach. J. Nucl. Med. 52, 733-740 (2011).
-
(2011)
J. Nucl. Med
, vol.52
, pp. 733-740
-
-
Südmeyer, M.1
-
31
-
-
84867507249
-
[18F] FDG-PET is superior to [123I]IBZM-SPECT for the differential diagnosis of parkinsonism
-
Hellwig, S. et al. [18F]FDG-PET is superior to [123I]IBZM-SPECT for the differential diagnosis of parkinsonism. Neurology 79, 1314-1322 (2012).
-
(2012)
Neurology
, vol.79
, pp. 1314-1322
-
-
Hellwig, S.1
-
32
-
-
35948961138
-
Meta-analysis of the literature on diagnostic accuracy of SPECT in parkinsonian syndromes
-
Vlaar, A. M., van Kroonenburgh, M. J., Kessels, A. G. & Weber, W. E. Meta-analysis of the literature on diagnostic accuracy of SPECT in parkinsonian syndromes. BMC Neurol. 7, 27 (2007).
-
(2007)
BMC Neurol
, vol.7
, pp. 27
-
-
Vlaar, A.M.1
Van Kroonenburgh, M.J.2
Kessels, A.G.3
Weber, W.E.4
-
33
-
-
0242288107
-
Dopamine transporter imaging and SPECT in diagnostic work-up of Parkinson's disease: A decision-analytic approach
-
Dodel, R. C. et al. Dopamine transporter imaging and SPECT in diagnostic work-up of Parkinson's disease: a decision-analytic approach. Mov. Disord. 18, S52-S62 (2003).
-
(2003)
Mov. Disord
, vol.18
, pp. S52-S62
-
-
Dodel, R.C.1
-
34
-
-
57749208525
-
Cost-effectiveness of 123I-FP-CIT SPECT in the differential diagnosis of essential tremor and Parkinson's disease in Italy
-
Antonini, A. et al. Cost-effectiveness of 123I-FP-CIT SPECT in the differential diagnosis of essential tremor and Parkinson's disease in Italy. Mov. Disord. 23, 2202-2209 (2008).
-
(2008)
Mov. Disord
, vol.23
, pp. 2202-2209
-
-
Antonini, A.1
-
35
-
-
0033933435
-
Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers
-
Lavalaye, J., Booij, J., Reneman, L., Habraken, J. B. & van Royen, E. A. Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers. Eur. J. Nucl. Med. 27, 867-869 (2000).
-
(2000)
Eur. J. Nucl. Med
, vol.27
, pp. 867-869
-
-
Lavalaye, J.1
Booij, J.2
Reneman, L.3
Habraken, J.B.4
Van Royen, E.A.5
-
36
-
-
33646459451
-
A responder analysis of memantine treatment in patients with Alzheimer disease maintained on donepezil
-
van Dyck, C. H. et al. A responder analysis of memantine treatment in patients with Alzheimer disease maintained on donepezil. Am. J. Geriatr. Psychiatry 14, 428-437 (2006).
-
(2006)
Am. J. Geriatr. Psychiatry
, vol.14
, pp. 428-437
-
-
Van Dyck, C.H.1
-
37
-
-
0028219583
-
Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: Discriminant analysis of striatal 18F-dopa PET data
-
Burn, D. J., Sawle, G. V. & Brooks, D. J. Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data. J. Neurol. Neurosurg. Psychiatry 57, 278-284 (1994).
-
(1994)
J. Neurol. Neurosurg. Psychiatry
, vol.57
, pp. 278-284
-
-
Burn, D.J.1
Sawle, G.V.2
Brooks, D.J.3
-
38
-
-
0028271363
-
Separating Parkinson's disease from normality. Discriminant function analysis of fluorodopa F 18 positron emission tomography data
-
Sawle, G. V., Playford, E. D., Burn, D. J., Cunningham, V. J. & Brooks, D. J. Separating Parkinson's disease from normality. Discriminant function analysis of fluorodopa F 18 positron emission tomography data. Arch. Neurol. 51, 237-243 (1994).
-
(1994)
Arch. Neurol
, vol.51
, pp. 237-243
-
-
Sawle, G.V.1
Playford, E.D.2
Burn, D.J.3
Cunningham, V.J.4
Brooks, D.J.5
-
39
-
-
3943053477
-
The dopamine D2 receptor ligand 18F-desmethoxy-fallypride: An appropriate fluorinated PET tracer for the differential diagnosis of parkinsonism
-
Schreckenberger, M. et al. The dopamine D2 receptor ligand 18F-desmethoxy-fallypride: an appropriate fluorinated PET tracer for the differential diagnosis of parkinsonism. Eur. J. Nucl. Med. Mol. Imaging 31, 1128-1135 (2004).
-
(2004)
Eur. J. Nucl. Med. Mol. Imaging
, vol.31
, pp. 1128-1135
-
-
Schreckenberger, M.1
-
40
-
-
84874222032
-
Differential diagnosis of Parkinsonism using dual-phase F-18 FP-CIT PET imaging
-
Jin, S. et al. Differential diagnosis of Parkinsonism using dual-phase F-18 FP-CIT PET imaging. Nucl. Med. Mol. Imaging 47, 44-51 (2013).
-
(2013)
Nucl. Med. Mol. Imaging
, vol.47
, pp. 44-51
-
-
Jin, S.1
-
41
-
-
10344229443
-
Comparative nigrostriatal dopaminergic imaging with iodine-123-βCIT-FP/SPECT and fluorine-18-FDOPA/PET
-
Ishikawa, T. et al. Comparative nigrostriatal dopaminergic imaging with iodine-123-βCIT-FP/SPECT and fluorine-18-FDOPA/PET. J. Nucl. Med. 37, 1760-1765 (1996).
-
(1996)
J. Nucl. Med
, vol.37
, pp. 1760-1765
-
-
Ishikawa, T.1
-
42
-
-
31444451405
-
Comparison of FP-CIT SPECT with F-DOPA PET in patients with de novo and advanced Parkinson's disease
-
Eshuis, S. A., Maguire, R. P., Leenders, K. L., Jonkman, S. & Jager, P. L. Comparison of FP-CIT SPECT with F-DOPA PET in patients with de novo and advanced Parkinson's disease. Eur. J. Nucl. Med. Mol. Imaging 33, 200-209 (2006).
-
(2006)
Eur. J. Nucl. Med. Mol. Imaging
, vol.33
, pp. 200-209
-
-
Eshuis, S.A.1
Maguire, R.P.2
Leenders, K.L.3
Jonkman, S.4
Jager, P.L.5
-
43
-
-
3843060242
-
Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET
-
Juh, R., Kim, J., Moon, D., Choe, B. & Suh, T. Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET. Eur. J. Radiol. 51, 223-233 (2004).
-
(2004)
Eur. J. Radiol
, vol.51
, pp. 223-233
-
-
Juh, R.1
Kim, J.2
Moon, D.3
Choe, B.4
Suh, T.5
-
44
-
-
0029401262
-
Early differential diagnosis of Parkinson's disease with 18F-fluorodeoxyglucose and positron emission tomography
-
Eidelberg, D. et al. Early differential diagnosis of Parkinson's disease with 18F-fluorodeoxyglucose and positron emission tomography. Neurology 45, 1995-2004 (1995).
-
(1995)
Neurology
, vol.45
, pp. 1995-2004
-
-
Eidelberg, D.1
-
45
-
-
20444436869
-
FDG PET in the differential diagnosis of parkinsonian disorders
-
Eckert, T. et al. FDG PET in the differential diagnosis of parkinsonian disorders. Neuroimage 26, 912-921 (2005).
-
(2005)
Neuroimage
, vol.26
, pp. 912-921
-
-
Eckert, T.1
-
46
-
-
84876143207
-
Validation of parkinsonian disease-related metabolic brain patterns
-
Teune, L. K. et al. Validation of parkinsonian disease-related metabolic brain patterns. Mov. Disord. 28, 547-551 (2013).
-
(2013)
Mov. Disord
, vol.28
, pp. 547-551
-
-
Teune, L.K.1
-
47
-
-
76249130565
-
Differential diagnosis of parkinsonism: A metabolic imaging study using pattern analysis
-
Tang, C. C. et al. Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis. Lancet Neurol. 9, 149-158 (2010).
-
(2010)
Lancet Neurol
, vol.9
, pp. 149-158
-
-
Tang, C.C.1
-
48
-
-
16444384151
-
Cost-effectiveness of 18F-fluorodeoxyglucose positron emission tomography in the assessment of early dementia from a Belgian and European perspective
-
Moulin-Romsee, G., Maes, A., Silverman, D., Mortelmans, L. & Van Laere, K. Cost-effectiveness of 18F-fluorodeoxyglucose positron emission tomography in the assessment of early dementia from a Belgian and European perspective. Eur. J. Neurol. 12, 254-63 (2005).
-
(2005)
Eur. J. Neurol
, vol.12
, pp. 254-263
-
-
Moulin-Romsee, G.1
Maes, A.2
Silverman, D.3
Mortelmans, L.4
Van Laere, K.5
-
49
-
-
0036120810
-
Thin section MR study of the basal ganglia in the differential diagnosis between striatonigral degeneration and Parkinson disease
-
Righini, A. et al. Thin section MR study of the basal ganglia in the differential diagnosis between striatonigral degeneration and Parkinson disease. J. Comput. Assist. Tomogr. 26, 266-271 (2002).
-
(2002)
J. Comput. Assist. Tomogr
, vol.26
, pp. 266-271
-
-
Righini, A.1
-
50
-
-
70349651971
-
Degenerative changes were common in brain magnetic resonance imaging in patients with newly diagnosed Parkinson's disease in a population-based cohort
-
Linder, J. et al. Degenerative changes were common in brain magnetic resonance imaging in patients with newly diagnosed Parkinson's disease in a population-based cohort. J. Neurol. 256, 1671-1680 (2009).
-
(2009)
J. Neurol
, vol.256
, pp. 1671-1680
-
-
Linder, J.1
-
51
-
-
5644288451
-
Voxel-based morphometry detects patterns of atrophy that help differentiate progressive supranuclear palsy and Parkinson's disease
-
Price, S. et al. Voxel-based morphometry detects patterns of atrophy that help differentiate progressive supranuclear palsy and Parkinson's disease. Neuroimage 23, 663-669 (2004).
-
(2004)
Neuroimage
, vol.23
, pp. 663-669
-
-
Price, S.1
-
52
-
-
13844314087
-
Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy
-
Paviour, D. C., Price, S. L., Stevens, J. M., Lees, A. J. & Fox, N. C. Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy. Neurology 64, 675-679 (2005).
-
(2005)
Neurology
, vol.64
, pp. 675-679
-
-
Paviour, D.C.1
Price, S.L.2
Stevens, J.M.3
Lees, A.J.4
Fox, N.C.5
-
53
-
-
84876522550
-
Differential diagnosis tool for parkinsonian syndrome using multiple structural brain measures
-
Ota, M. et al. Differential diagnosis tool for parkinsonian syndrome using multiple structural brain measures. Comput. Math. Methods Med. 2013, 571289 (2013).
-
(2013)
Comput. Math. Methods Med
, vol.2013
, pp. 571289
-
-
Ota, M.1
-
54
-
-
84880293475
-
Automated, high accuracy classification of Parkinsonian disorders: A pattern recognition approach
-
Marquand, A. F. et al. Automated, high accuracy classification of Parkinsonian disorders: a pattern recognition approach. PLoS ONE 8, e69237 (2013).
-
(2013)
PLoS ONE
, vol.8
-
-
Marquand, A.F.1
-
55
-
-
0037176815
-
Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD
-
Schocke, M. F. et al. Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD. Neurology 58, 575-580 (2002).
-
(2002)
Neurology
, vol.58
, pp. 575-580
-
-
Schocke, M.F.1
-
56
-
-
0037465774
-
Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy
-
Seppi, K. et al. Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy. Neurology 60, 922-927 (2003).
-
(2003)
Neurology
, vol.60
, pp. 922-927
-
-
Seppi, K.1
-
57
-
-
84920945580
-
Usefulness of proton and phosphorus MR spectroscopic imaging for early diagnosis of Parkinson's disease
-
Weiduschat, N. et al. Usefulness of proton and phosphorus MR spectroscopic imaging for early diagnosis of Parkinson's disease. J. Neuroimaging http://dx.doi.org/10.1111/jon.12074.
-
J. Neuroimaging
-
-
Weiduschat, N.1
-
58
-
-
0034935922
-
Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings
-
Berg, D., Siefker, C. & Becker, G. Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings. J. Neurol. 248, 684-689 (2001).
-
(2001)
J. Neurol
, vol.248
, pp. 684-689
-
-
Berg, D.1
Siefker, C.2
Becker, G.3
-
59
-
-
0037435514
-
Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes
-
Walter, U. et al. Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes. Neurology 60, 74-77 (2003).
-
(2003)
Neurology
, vol.60
, pp. 74-77
-
-
Walter, U.1
-
60
-
-
3543098625
-
Sonographic discrimination of corticobasal degeneration vs progressive supranuclear palsy
-
Walter, U. et al. Sonographic discrimination of corticobasal degeneration vs progressive supranuclear palsy. Neurology 63, 504-509 (2004).
-
(2004)
Neurology
, vol.63
, pp. 504-509
-
-
Walter, U.1
-
61
-
-
41949137200
-
The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: A prospective blinded study
-
Gaenslen, A. et al. The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded study. Lancet Neurol. 7, 417-424 (2008).
-
(2008)
Lancet Neurol
, vol.7
, pp. 417-424
-
-
Gaenslen, A.1
-
62
-
-
84899977467
-
Transcranial sonography and [18F]fluorodeoxyglucose positron emission tomography for the differential diagnosis of parkinsonism: A head-to-head comparison
-
Hellwig, S. et al. Transcranial sonography and [18F]fluorodeoxyglucose positron emission tomography for the differential diagnosis of parkinsonism: a head-to-head comparison. Eur. J. Neurol. 21, 860-866 (2014).
-
(2014)
Eur. J. Neurol
, vol.21
, pp. 860-866
-
-
Hellwig, S.1
-
63
-
-
84877707641
-
Specificity and sensitivity of transcranial sonography of the substantia nigra in the diagnosis of Parkinson's disease: Prospective cohort study in 196 patients
-
Bouwmans, A. E., Vlaar, A. M., Mess, W. H., Kessels, A. & Weber, W. E. Specificity and sensitivity of transcranial sonography of the substantia nigra in the diagnosis of Parkinson's disease: prospective cohort study in 196 patients. BMJ Open 3, e002613 (2013).
-
(2013)
BMJ Open
, vol.3
-
-
Bouwmans, A.E.1
Vlaar, A.M.2
Mess, W.H.3
Kessels, A.4
Weber, W.E.5
-
64
-
-
0035412899
-
Rate of progression in Parkinson's disease: A 6-[18F]fluoro-l-dopa PET study
-
Nurmi, E. et al. Rate of progression in Parkinson's disease: a 6-[18F]fluoro-l-dopa PET study. Mov. Disord. 16, 608-615 (2001).
-
(2001)
Mov. Disord
, vol.16
, pp. 608-615
-
-
Nurmi, E.1
-
65
-
-
79955484858
-
Progression of monoaminergic dysfunction in Parkinson's disease: A longitudinal 18F-dopa PET study
-
Pavese, N., Rivero-Bosch, M., Lewis, S. J., Whone, A. L. & Brooks, D. J. Progression of monoaminergic dysfunction in Parkinson's disease: a longitudinal 18F-dopa PET study. Neuroimage 56, 1463-1468 (2011).
-
(2011)
Neuroimage
, vol.56
, pp. 1463-1468
-
-
Pavese, N.1
Rivero-Bosch, M.2
Lewis, S.J.3
Whone, A.L.4
Brooks, D.J.5
-
66
-
-
67651177750
-
A follow-up study on 6-[18F]fluoro-l-dopa uptake in early Parkinson's disease shows nonlinear progression in the putamen
-
Brück, A. et al. A follow-up study on 6-[18F]fluoro-l-dopa uptake in early Parkinson's disease shows nonlinear progression in the putamen. Mov. Disord. 24, 1009-1015 (2009).
-
(2009)
Mov. Disord
, vol.24
, pp. 1009-1015
-
-
Brück, A.1
-
67
-
-
70350678559
-
Longitudinal progression of sporadic Parkinson's disease: A multi-tracer positron emission tomography study
-
Nandhagopal, R. et al. Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study. Brain 132, 2970-2979 (2009).
-
(2009)
Brain
, vol.132
, pp. 2970-2979
-
-
Nandhagopal, R.1
-
68
-
-
14844300111
-
Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity
-
Hilker, R. et al. Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity. Arch. Neurol. 62, 378-382 (2005).
-
(2005)
Arch. Neurol
, vol.62
, pp. 378-382
-
-
Hilker, R.1
-
69
-
-
18844471416
-
In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease
-
Lee, C. S. In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease. Ann. Neurol. 47, 493-503 (2000).
-
(2000)
Ann. Neurol
, vol.47
, pp. 493-503
-
-
Lee, C.S.1
-
70
-
-
79955466566
-
Age-specific progression of nigrostriatal dysfunction in Parkinson's disease
-
de la Fuente-Fernández, R. et al. Age-specific progression of nigrostriatal dysfunction in Parkinson's disease. Ann. Neurol. 69, 803-810 (2011).
-
(2011)
Ann. Neurol
, vol.69
, pp. 803-810
-
-
De La Fuente-Fernández, R.1
-
71
-
-
0025065388
-
Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy
-
Brooks, D. J. et al. Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. Ann. Neurol. 28, 547-555 (1990).
-
(1990)
Ann. Neurol
, vol.28
, pp. 547-555
-
-
Brooks, D.J.1
-
72
-
-
34447636064
-
Changes in network activity with the progression of Parkinson's disease
-
Huang, C. et al. Changes in network activity with the progression of Parkinson's disease. Brain 130, 1834-1846 (2007).
-
(2007)
Brain
, vol.130
, pp. 1834-1846
-
-
Huang, C.1
-
73
-
-
75749128636
-
Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease
-
Tang, C. C., Poston, K. L., Dhawan, V. & Eidelberg, D. Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease. J. Neurosci. 30, 1049-1056 (2010).
-
(2010)
J. Neurosci
, vol.30
, pp. 1049-1056
-
-
Tang, C.C.1
Poston, K.L.2
Dhawan, V.3
Eidelberg, D.4
-
74
-
-
84871724455
-
Progression of cortical thinning in early Parkinson's disease
-
Ibarretxe-Bilbao, N. et al. Progression of cortical thinning in early Parkinson's disease. Mov. Disord. 27, 1746-1753 (2012).
-
(2012)
Mov. Disord
, vol.27
, pp. 1746-1753
-
-
Ibarretxe-Bilbao, N.1
-
75
-
-
84855428685
-
Cortical hypoperfusion in Parkinson's disease assessed using arterial spin labeled perfusion MRI
-
Fernández-Seara, M. A. et al. Cortical hypoperfusion in Parkinson's disease assessed using arterial spin labeled perfusion MRI. Neuroimage 59, 2743-2750 (2012).
-
(2012)
Neuroimage
, vol.59
, pp. 2743-2750
-
-
Fernández-Seara, M.A.1
-
76
-
-
84871754989
-
Resting state functional connectivity of the striatum in Parkinson's disease
-
Hacker, C. D., Perlmutter, J. S., Criswell, S. R., Ances, B. M. & Snyder, A. Z. Resting state functional connectivity of the striatum in Parkinson's disease. Brain 135, 3699-3711 (2012).
-
(2012)
Brain
, vol.135
, pp. 3699-3711
-
-
Hacker, C.D.1
Perlmutter, J.S.2
Criswell, S.R.3
Ances, B.M.4
Snyder, A.Z.5
-
77
-
-
84876330064
-
Diffusion tensor imaging in parkinsonian syndromes: A systematic review and meta-analysis
-
Cochrane, C. J. & Ebmeier, K. P. Diffusion tensor imaging in parkinsonian syndromes: a systematic review and meta-analysis. Neurology 80, 857-864 (2013).
-
(2013)
Neurology
, vol.80
, pp. 857-864
-
-
Cochrane, C.J.1
Ebmeier, K.P.2
-
78
-
-
77955905072
-
Characterizing iron deposition in Parkinson's disease using susceptibility-weighted imaging: An in vivo MR study
-
Zhang, J. et al. Characterizing iron deposition in Parkinson's disease using susceptibility-weighted imaging: an in vivo MR study. Brain Res. 1330, 124-130 (2010).
-
(2010)
Brain Res
, vol.1330
, pp. 124-130
-
-
Zhang, J.1
-
79
-
-
84876412536
-
Changes in substantia nigra and locus coeruleus in patients with early-stage Parkinson's disease using neuromelanin-sensitive MR imaging
-
Ohtsuka, C. et al. Changes in substantia nigra and locus coeruleus in patients with early-stage Parkinson's disease using neuromelanin-sensitive MR imaging. Neurosci. Lett. 541, 93-98 (2013).
-
(2013)
Neurosci. Lett
, vol.541
, pp. 93-98
-
-
Ohtsuka, C.1
-
80
-
-
0030614902
-
[123I] FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease
-
Booij, J. et al. [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 62, 133-140 (1997).
-
(1997)
J. Neurol. Neurosurg. Psychiatry
, vol.62
, pp. 133-140
-
-
Booij, J.1
-
81
-
-
0035846468
-
[123I] β-CIT SPECT imaging assessment of the rate of Parkinson's disease progression
-
Marek, K. et al. [123I]β-CIT SPECT imaging assessment of the rate of Parkinson's disease progression. Neurology 57, 2089-2094 (2001).
-
(2001)
Neurology
, vol.57
, pp. 2089-2094
-
-
Marek, K.1
-
82
-
-
0029670370
-
Differences in the reduced 18F-Dopa uptakes of the caudate and the putamen in Parkinson's disease: Correlations with the three main symptoms
-
Otsuka, M. et al. Differences in the reduced 18F-Dopa uptakes of the caudate and the putamen in Parkinson's disease: correlations with the three main symptoms. J. Neurol. Sci. 136, 169-173 (1996).
-
(1996)
J. Neurol. Sci
, vol.136
, pp. 169-173
-
-
Otsuka, M.1
-
83
-
-
1842290405
-
Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion?
-
Vingerhoets, F. J., Schulzer, M., Calne, D. B. & Snow, B. J. Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion? Ann. Neurol. 41, 58-64 (1997).
-
(1997)
Ann. Neurol
, vol.41
, pp. 58-64
-
-
Vingerhoets, F.J.1
Schulzer, M.2
Calne, D.B.3
Snow, B.J.4
-
84
-
-
0032776109
-
The relation of putamen and caudate nucleus 18F-Dopa uptake to motor and cognitive performances in Parkinson's disease
-
Broussolle, E. et al. The relation of putamen and caudate nucleus 18F-Dopa uptake to motor and cognitive performances in Parkinson's disease. J. Neurol. Sci. 166, 141-151 (1999).
-
(1999)
J. Neurol. Sci
, vol.166
, pp. 141-151
-
-
Broussolle, E.1
-
85
-
-
84902206494
-
Correlation of Parkinson disease severity and 18F-DTBZ positron emission tomography
-
Hsiao, I. T. et al. Correlation of Parkinson disease severity and 18F-DTBZ positron emission tomography. JAMA Neurol. 71, 758-766 (2014).
-
(2014)
JAMA Neurol
, vol.71
, pp. 758-766
-
-
Hsiao, I.T.1
-
86
-
-
33750975077
-
Clinical correlates of levodopa-induced dopamine release in Parkinson disease: A PET study
-
Pavese, N. et al. Clinical correlates of levodopa-induced dopamine release in Parkinson disease: a PET study. Neurology 67, 1612-1617 (2006).
-
(2006)
Neurology
, vol.67
, pp. 1612-1617
-
-
Pavese, N.1
-
87
-
-
84896751626
-
Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson's disease patients
-
Politis, M. et al. Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson's disease patients. J. Clin. Invest. 124, 1340-1349 (2014).
-
(2014)
J. Clin. Invest
, vol.124
, pp. 1340-1349
-
-
Politis, M.1
-
88
-
-
84872525238
-
Differences in brain activation between tremor- and nontremor-dominant Parkinson disease
-
Prodoehl, J. et al. Differences in brain activation between tremor- and nontremor-dominant Parkinson disease. JAMA Neurol. 70, 100-106 (2013).
-
(2013)
JAMA Neurol
, vol.70
, pp. 100-106
-
-
Prodoehl, J.1
-
89
-
-
0037465371
-
Tremor in Parkinson's disease and serotonergic dysfunction: An 11C-WAY 100635 PET study
-
Doder, M., Rabiner, E. A., Turjanski, N., Lees, A. J. & Brooks, D. J. Tremor in Parkinson's disease and serotonergic dysfunction: an 11C-WAY 100635 PET study. Neurology 60, 601-605 (2003).
-
(2003)
Neurology
, vol.60
, pp. 601-605
-
-
Doder, M.1
Rabiner, E.A.2
Turjanski, N.3
Lees, A.J.4
Brooks, D.J.5
-
90
-
-
0026767497
-
Isolated tremor and disruption of the nigrostriatal dopaminergic system: An 18F-dopa PET study
-
Brooks, D. J. et al. Isolated tremor and disruption of the nigrostriatal dopaminergic system: an 18F-dopa PET study. Neurology 42, 1554-1560 (1992).
-
(1992)
Neurology
, vol.42
, pp. 1554-1560
-
-
Brooks, D.J.1
-
91
-
-
0033955756
-
Evidence for impaired presynaptic dopamine function in parkinsonian patients with motor fluctuations
-
de la Fuente-Fernández, R. et al. Evidence for impaired presynaptic dopamine function in parkinsonian patients with motor fluctuations. J. Neural Transm. 107, 49-57 (2000).
-
(2000)
J. Neural Transm
, vol.107
, pp. 49-57
-
-
De La Fuente-Fernández, R.1
-
92
-
-
84879112972
-
Serotonergic loss in motor circuitries correlates with severity of action-postural tremor in PD
-
Loane, C. et al. Serotonergic loss in motor circuitries correlates with severity of action-postural tremor in PD. Neurology 80, 1850-1855 (2013).
-
(2013)
Neurology
, vol.80
, pp. 1850-1855
-
-
Loane, C.1
-
93
-
-
73449090105
-
History of falls in Parkinson disease is associated with reduced cholinergic activity
-
Bohnen, N. I. et al. History of falls in Parkinson disease is associated with reduced cholinergic activity. Neurology 73, 1670-1676 (2009).
-
(2009)
Neurology
, vol.73
, pp. 1670-1676
-
-
Bohnen, N.I.1
-
94
-
-
0034167437
-
The pedunculopontine nucleus: Its role in the genesis of movement disorders
-
Lee, M. S., Rinne, J. O. & Marsden, C. D. The pedunculopontine nucleus: its role in the genesis of movement disorders. Yonsei Med. J. 41, 167-184 (2000).
-
(2000)
Yonsei Med. J
, vol.41
, pp. 167-184
-
-
Lee, M.S.1
Rinne, J.O.2
Marsden, C.D.3
-
95
-
-
84867772010
-
Regional gray matter atrophy in patients with Parkinson disease and freezing of gait
-
Tessitore, A. et al. Regional gray matter atrophy in patients with Parkinson disease and freezing of gait. AJNR Am. J. Neuroradiol. 33, 1804-1809 (2012).
-
(2012)
AJNR Am. J. Neuroradiol
, vol.33
, pp. 1804-1809
-
-
Tessitore, A.1
-
96
-
-
84858130465
-
Pattern of brain tissue loss associated with freezing of gait in Parkinson disease
-
Kostic, V. S. et al. Pattern of brain tissue loss associated with freezing of gait in Parkinson disease. Neurology 78, 409-416 (2012).
-
(2012)
Neurology
, vol.78
, pp. 409-416
-
-
Kostic, V.S.1
-
97
-
-
84876037711
-
Exploring the cortical and subcortical functional magnetic resonance imaging changes associated with freezing in Parkinson's disease
-
Shine, J. M. et al. Exploring the cortical and subcortical functional magnetic resonance imaging changes associated with freezing in Parkinson's disease. Brain 136, 1204-1215 (2013).
-
(2013)
Brain
, vol.136
, pp. 1204-1215
-
-
Shine, J.M.1
-
98
-
-
33750315667
-
Striatal dopa and glucose metabolism in PD patients with freezing of gait
-
Bartels, A. L. et al. Striatal dopa and glucose metabolism in PD patients with freezing of gait. Mov. Disord. 21, 1326-1332 (2006).
-
(2006)
Mov. Disord
, vol.21
, pp. 1326-1332
-
-
Bartels, A.L.1
-
99
-
-
84897957033
-
Dyskinesias in Parkinson's disease: Views from positron emission tomography studies
-
Niccolini, F., Loane, C. & Politis, M. Dyskinesias in Parkinson's disease: views from positron emission tomography studies. Eur. J. Neurol. 21, 694-699 (2014).
-
(2014)
Eur. J. Neurol
, vol.21
, pp. 694-699
-
-
Niccolini, F.1
Loane, C.2
Politis, M.3
-
100
-
-
65249107128
-
PET demonstrates reduced dopamine transporter expression in PD with dyskinesias
-
Troiano, A. R., de la Fuente-Fernández, R. & Sossi, V. PET demonstrates reduced dopamine transporter expression in PD with dyskinesias. Neurology 72, 1211-1216 (2009).
-
(2009)
Neurology
, vol.72
, pp. 1211-1216
-
-
Troiano, A.R.1
De La Fuente-Fernández, R.2
Sossi, V.3
-
101
-
-
0035092779
-
Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnover
-
de la Fuente-Fernández, R. et al. Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnover. Ann. Neurol. 49, 298-303 (2001).
-
(2001)
Ann. Neurol
, vol.49
, pp. 298-303
-
-
De La Fuente-Fernández, R.1
-
102
-
-
10344236071
-
Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: Implications for dyskinesias
-
de la Fuente- Fernández, R. et al. Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias. Brain 127, 2747-2754 (2004).
-
(2004)
Brain
, vol.127
, pp. 2747-2754
-
-
De La Fuente-Fernández, R.1
-
103
-
-
34247262201
-
Reduced substance P binding in Parkinson's disease complicated by dyskinesias: An F-18-L829165 PET study
-
Whone, A. L. et al. Reduced substance P binding in Parkinson's disease complicated by dyskinesias: an F-18-L829165 PET study. Neurology 58 (Suppl. 3), A488-A449 (2002).
-
(2002)
Neurology
, vol.58
, pp. A488-A449
-
-
Whone, A.L.1
-
104
-
-
79958163183
-
Adenosine 2A receptor availability in dyskinetic and nondyskinetic patients with Parkinson disease
-
Ramlackhansingh, A. F. et al. Adenosine 2A receptor availability in dyskinetic and nondyskinetic patients with Parkinson disease. Neurology 76, 1811-1816 (2011).
-
(2011)
Neurology
, vol.76
, pp. 1811-1816
-
-
Ramlackhansingh, A.F.1
-
105
-
-
79952234223
-
Adenosine A2A receptors measured with [11C]TMSX PET in the striata of Parkinson's Disease patients
-
Mishina, M. et al. Adenosine A2A receptors measured with [11C]TMSX PET in the striata of Parkinson's Disease patients. PLoS ONE 6, e17338 (2011).
-
(2011)
PLoS ONE
, vol.6
-
-
Mishina, M.1
-
106
-
-
79953647380
-
Glutamate NMDA receptor dysregulation in Parkinson's disease with dyskinesias
-
Ahmed, I. et al. Glutamate NMDA receptor dysregulation in Parkinson's disease with dyskinesias. Brain 134, 979-986 (2011).
-
(2011)
Brain
, vol.134
, pp. 979-986
-
-
Ahmed, I.1
-
107
-
-
32544432029
-
Non-motor symptoms of Parkinson's disease: Diagnosis and management
-
Chaudhuri, K. R., Healy, D. G. & Schapira, A. H. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol. 5, 235-245 (2006).
-
(2006)
Lancet Neurol
, vol.5
, pp. 235-245
-
-
Chaudhuri, K.R.1
Healy, D.G.2
Schapira, A.H.3
-
108
-
-
54049120959
-
Evidence of dopamine dysfunction in the hypothalamus of patients with Parkinson's disease: An in vivo 11C-raclopride PET study
-
Politis, M., Piccini, P., Pavese, N., Koh, S. B. & Brooks, D. J. Evidence of dopamine dysfunction in the hypothalamus of patients with Parkinson's disease: an in vivo 11C-raclopride PET study. Exp. Neurol. 214, 112-116 (2008).
-
(2008)
Exp. Neurol
, vol.214
, pp. 112-116
-
-
Politis, M.1
Piccini, P.2
Pavese, N.3
Koh, S.B.4
Brooks, D.J.5
-
109
-
-
84859496019
-
Serotonin neuron loss and nonmotor symptoms continue in Parkinson's patients treated with dopamine grafts
-
Politis, M. et al. Serotonin neuron loss and nonmotor symptoms continue in Parkinson's patients treated with dopamine grafts. Sci. Transl. Med. 4, 128ra41 (2012).
-
(2012)
Sci. Transl. Med
, vol.4
-
-
Politis, M.1
-
110
-
-
0036589970
-
Beyond the iron mask: Towards better recognition and treatment of depression associated with Parkinson's disease
-
Burn, D. J. Beyond the iron mask: towards better recognition and treatment of depression associated with Parkinson's disease. Mov. Disord. 17, 445-454 (2002).
-
(2002)
Mov. Disord
, vol.17
, pp. 445-454
-
-
Burn, D.J.1
-
111
-
-
20444477480
-
Depression in Parkinson's disease: Loss of dopamine and noradrenaline innervation in the limbic system
-
Remy, P., Doder, M., Lees, A., Turjanski, N. & Brooks, D. Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 128, 1314-1322 (2005).
-
(2005)
Brain
, vol.128
, pp. 1314-1322
-
-
Remy, P.1
Doder, M.2
Lees, A.3
Turjanski, N.4
Brooks, D.5
-
112
-
-
0000296112
-
Brain serotonin HT1A receptors in Parkinson's disease with and without depression measured by positron emission tomography and 11C-WAY100635
-
Doder, M., Rabiner, E. A., Turjanski, N., Lees, A. J. & Brooks, D. J. Brain serotonin HT1A receptors in Parkinson's disease with and without depression measured by positron emission tomography and 11C-WAY100635. Mov. Disord. 15 (Suppl. 3), 213 (2000).
-
(2000)
Mov. Disord
, vol.15
, pp. 213
-
-
Doder, M.1
Rabiner, E.A.2
Turjanski, N.3
Lees, A.J.4
Brooks, D.J.5
-
113
-
-
57049114907
-
Elevated serotonin transporter binding in depressed patients with Parkinson's disease: A preliminary PET study with [11C]DASB
-
Boileau, I. et al. Elevated serotonin transporter binding in depressed patients with Parkinson's disease: a preliminary PET study with [11C]DASB. Mov. Disord. 23, 1776-1780 (2008).
-
(2008)
Mov. Disord
, vol.23
, pp. 1776-1780
-
-
Boileau, I.1
-
114
-
-
78650030521
-
Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures
-
Politis, M. et al. Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures. Neurology 75, 1920-1927 (2010).
-
(2010)
Neurology
, vol.75
, pp. 1920-1927
-
-
Politis, M.1
-
115
-
-
84855920924
-
Role of serotonergic 1A receptor dysfunction in depression associated with Parkinson's disease
-
Ballanger, B. et al. Role of serotonergic 1A receptor dysfunction in depression associated with Parkinson's disease. Mov. Disord. 27, 84-89 (2012).
-
(2012)
Mov. Disord
, vol.27
, pp. 84-89
-
-
Ballanger, B.1
-
116
-
-
11444270248
-
Hallucinations and sleep disorders in PD: Six-year prospective longitudinal study
-
Goetz, C. G., Wuu, J., Curgian, L. M. & Leurgans, S. Hallucinations and sleep disorders in PD: six-year prospective longitudinal study. Neurology 64, 81-86 (2005).
-
(2005)
Neurology
, vol.64
, pp. 81-86
-
-
Goetz, C.G.1
Wuu, J.2
Curgian, L.M.3
Leurgans, S.4
-
117
-
-
0041883808
-
[18F] fluorodopa uptake in the upper brainstem measured with positron emission tomography correlates with decreased REM sleep duration in early Parkinson's disease
-
Hilker, R. et al. [18F]fluorodopa uptake in the upper brainstem measured with positron emission tomography correlates with decreased REM sleep duration in early Parkinson's disease. Clin. Neurol. Neurosurg. 105, 262-269 (2003).
-
(2003)
Clin. Neurol. Neurosurg
, vol.105
, pp. 262-269
-
-
Hilker, R.1
-
118
-
-
84860122434
-
Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease
-
Kotagal, V. et al. Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease. Ann. Neurol. 71, 560-568 (2012).
-
(2012)
Ann. Neurol
, vol.71
, pp. 560-568
-
-
Kotagal, V.1
-
119
-
-
84863630897
-
The role of serotonin in sleep disordered breathing associated with Parkinson disease: A correlative [11C]DASB PET imaging study
-
Lelieveld, I. M. et al. The role of serotonin in sleep disordered breathing associated with Parkinson disease: a correlative [11C]DASB PET imaging study. PLoS ONE 7, e40166 (2012).
-
(2012)
PLoS ONE
, vol.7
-
-
Lelieveld, I.M.1
-
120
-
-
0036836047
-
Measuring fatigue in patients with Parkinson's disease - The Fatigue Severity Scale
-
Herlofson, K. & Larsen, J. P. Measuring fatigue in patients with Parkinson's disease-the Fatigue Severity Scale. Eur. J. Neurol. 9, 595-600 (2002).
-
(2002)
Eur. J. Neurol
, vol.9
, pp. 595-600
-
-
Herlofson, K.1
Larsen, J.P.2
-
121
-
-
78049460075
-
Fatigue in Parkinson's disease is linked to striatal and limbic serotonergic dysfunction
-
Pavese, N., Metta, V., Bose, S. K., Chaudhuri, K. R. & Brooks, D. J. Fatigue in Parkinson's disease is linked to striatal and limbic serotonergic dysfunction. Brain 133, 3434-3443 (2010).
-
(2010)
Brain
, vol.133
, pp. 3434-3443
-
-
Pavese, N.1
Metta, V.2
Bose, S.K.3
Chaudhuri, K.R.4
Brooks, D.J.5
-
122
-
-
0029082398
-
Weight change and body composition in patients with Parkinson's disease
-
Beyer, P. L., Palarino, M. Y., Michalek, D., Busenbark, K. & Koller, W. C. Weight change and body composition in patients with Parkinson's disease. J. Am. Diet. Assoc. 95, 979-983 (1995).
-
(1995)
J. Am. Diet. Assoc
, vol.95
, pp. 979-983
-
-
Beyer, P.L.1
Palarino, M.Y.2
Michalek, D.3
Busenbark, K.4
Koller, W.C.5
-
123
-
-
79960250055
-
Serotonergic mediated body mass index changes in Parkinson's disease
-
Politis, M., Loane, C., Wu, K., Brooks, D. J. & Piccini, P. Serotonergic mediated body mass index changes in Parkinson's disease. Neurobiol. Dis. 43, 609-615 (2011).
-
(2011)
Neurobiol. Dis
, vol.43
, pp. 609-615
-
-
Politis, M.1
Loane, C.2
Wu, K.3
Brooks, D.J.4
Piccini, P.5
-
124
-
-
77950894522
-
Serotonin 2A receptors and visual hallucinations in Parkinson disease
-
Ballanger, B. et al. Serotonin 2A receptors and visual hallucinations in Parkinson disease. Arch. Neurol. 67, 416-421 (2010).
-
(2010)
Arch. Neurol
, vol.67
, pp. 416-421
-
-
Ballanger, B.1
-
125
-
-
4344644880
-
Visual hallucination in Parkinson's disease with FDG PET
-
Nagano-Saito, A. et al. Visual hallucination in Parkinson's disease with FDG PET. Mov. Disord. 19, 801-806 (2004).
-
(2004)
Mov. Disord
, vol.19
, pp. 801-806
-
-
Nagano-Saito, A.1
-
126
-
-
32044447659
-
An estimate of the worldwide prevalence and direct costs of dementia in 2003
-
Wimo, A., Jonsson, L. & Winblad, B. An estimate of the worldwide prevalence and direct costs of dementia in 2003. Dement. Geriatr. Cogn. Disord. 21, 175-181 (2006).
-
(2006)
Dement. Geriatr. Cogn. Disord
, vol.21
, pp. 175-181
-
-
Wimo, A.1
Jonsson, L.2
Winblad, B.3
-
127
-
-
73249142830
-
Parkinson disease and impulse control disorders: A review of clinical features, pathophysiology and management
-
Wu, K., Politis, M. & Piccini, P. Parkinson disease and impulse control disorders: a review of clinical features, pathophysiology and management. Postgrad. Med. J. 85, 590-596 (2009).
-
(2009)
Postgrad. Med. J
, vol.85
, pp. 590-596
-
-
Wu, K.1
Politis, M.2
Piccini, P.3
-
128
-
-
84858666771
-
Impulse control disorders in Parkinson's disease
-
Vilas, D., Pont-Sunyer, C. & Tolosa, E. Impulse control disorders in Parkinson's disease. Parkinsonism Relat. Disord. 18 (Suppl. 1), S80-S84 (2012).
-
(2012)
Parkinsonism Relat. Disord
, vol.18
, pp. S80-S84
-
-
Vilas, D.1
Pont-Sunyer, C.2
Tolosa, E.3
-
129
-
-
33646358930
-
Compulsive drug use linked to sensitized ventral striatal dopamine transmission
-
Evans, A. H. et al. Compulsive drug use linked to sensitized ventral striatal dopamine transmission. Ann. Neurol. 59, 852-858 (2006).
-
(2006)
Ann. Neurol
, vol.59
, pp. 852-858
-
-
Evans, A.H.1
-
130
-
-
79953658757
-
Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours
-
O'Sullivan, S. S. et al. Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours. Brain 134, 969-978 (2011).
-
(2011)
Brain
, vol.134
, pp. 969-978
-
-
O'Sullivan, S.S.1
-
131
-
-
66549083459
-
Increased striatal dopamine release in Parkinsonian patients with pathological gambling: A [11C] raclopride PET study
-
Steeves, T. D. et al. Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain 132, 1376-1385 (2009).
-
(2009)
Brain
, vol.132
, pp. 1376-1385
-
-
Steeves, T.D.1
-
132
-
-
78649506636
-
Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD
-
van Eimeren, T. et al. Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD. Neurology 75, 1711-1716 (2010).
-
(2010)
Neurology
, vol.75
, pp. 1711-1716
-
-
Van Eimeren, T.1
-
133
-
-
84874341545
-
Neural response to visual sexual cues in dopamine treatment-linked hypersexuality in Parkinson's disease
-
Politis, M. et al. Neural response to visual sexual cues in dopamine treatment-linked hypersexuality in Parkinson's disease. Brain 136, 400-411 (2013).
-
(2013)
Brain
, vol.136
, pp. 400-411
-
-
Politis, M.1
-
134
-
-
27844469751
-
A systematic review of prevalence studies of dementia in Parkinson's disease
-
Aarsland, D., Zaccai, J. & Brayne, C. A systematic review of prevalence studies of dementia in Parkinson's disease. Mov. Disord. 20, 1255-1263 (2005).
-
(2005)
Mov. Disord
, vol.20
, pp. 1255-1263
-
-
Aarsland, D.1
Zaccai, J.2
Brayne, C.3
-
135
-
-
41149173996
-
The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
-
Hely, M. A., Reid, W. G., Adena, M. A., Halliday, G. M. & Morris, J. G. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov. Disord. 23, 837-844 (2008).
-
(2008)
Mov. Disord
, vol.23
, pp. 837-844
-
-
Hely, M.A.1
Reid, W.G.2
Adena, M.A.3
Halliday, G.M.4
Morris, J.G.5
-
136
-
-
0006164301
-
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop
-
McKeith, I. G. et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47, 1113-1124 (1996).
-
(1996)
Neurology
, vol.47
, pp. 1113-1124
-
-
McKeith, I.G.1
-
137
-
-
33144489150
-
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium
-
McKeith, I. G. et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65, 1863-1872 (2005).
-
(2005)
Neurology
, vol.65
, pp. 1863-1872
-
-
McKeith, I.G.1
-
138
-
-
0042970162
-
Dementia associated with Parkinson's disease
-
Emre, M. Dementia associated with Parkinson's disease. Lancet Neurol. 2, 229-237 (2003).
-
(2003)
Lancet Neurol
, vol.2
, pp. 229-237
-
-
Emre, M.1
-
139
-
-
84864698964
-
The catechol-O-methyltransferase Val158Met polymorphism modulates fronto-cortical dopamine turnover in early Parkinson's disease: A PET study
-
Wu, K. et al. The catechol-O-methyltransferase Val158Met polymorphism modulates fronto-cortical dopamine turnover in early Parkinson's disease: a PET study. Brain 135, 2449-2457 (2012).
-
(2012)
Brain
, vol.135
, pp. 2449-2457
-
-
Wu, K.1
-
140
-
-
0036260184
-
Striatal and extrastriatal dysfunction in Parkinson's disease with dementia: A 6-[18F]fluoro-l-dopa PET study
-
Ito, K. et al. Striatal and extrastriatal dysfunction in Parkinson's disease with dementia: a 6-[18F]fluoro-l-dopa PET study. Brain 125, 1358-1365 (2002).
-
(2002)
Brain
, vol.125
, pp. 1358-1365
-
-
Ito, K.1
-
141
-
-
2942586799
-
Cognitive- and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies
-
Nagano-Saito, A. et al. Cognitive- and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies. Neuroimage 22, 553-561 (2004).
-
(2004)
Neuroimage
, vol.22
, pp. 553-561
-
-
Nagano-Saito, A.1
-
142
-
-
33645078446
-
Dementia in Parkinson disease: Functional imaging of cholinergic and dopaminergic pathways
-
Hilker, R. et al. Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways. Neurology 65, 1716-1722 (2005).
-
(2005)
Neurology
, vol.65
, pp. 1716-1722
-
-
Hilker, R.1
-
143
-
-
77950511411
-
Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo
-
Klein, J. C. et al. Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo. Neurology 74, 885-892 (2010).
-
(2010)
Neurology
, vol.74
, pp. 885-892
-
-
Klein, J.C.1
-
144
-
-
79960197365
-
In vivo assessment of vesicular monoamine transporter type 2 in dementia with Lewy bodies and Alzheimer disease
-
Villemagne, V. L. et al. In vivo assessment of vesicular monoamine transporter type 2 in dementia with Lewy bodies and Alzheimer disease. Arch. Neurol. 68, 905-912 (2011).
-
(2011)
Arch. Neurol
, vol.68
, pp. 905-912
-
-
Villemagne, V.L.1
-
145
-
-
2342555065
-
Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: A comparison
-
Walker, Z. et al. Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: a comparison. Neurology 62, 1568-1572 (2004).
-
(2004)
Neurology
, vol.62
, pp. 1568-1572
-
-
Walker, Z.1
-
146
-
-
0030979769
-
Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity
-
Vander Borght, T. et al. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity. J. Nucl. Med. 38, 797-802 (1997).
-
(1997)
J. Nucl. Med
, vol.38
, pp. 797-802
-
-
Vander Borght, T.1
-
147
-
-
0034840946
-
Alzheimer's disease versus dementia with Lewy bodies: Cerebral metabolic distinction with autopsy confirmation
-
Minoshima, S. et al. Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Ann. Neurol. 50, 358-365 (2001).
-
(2001)
Ann. Neurol
, vol.50
, pp. 358-365
-
-
Minoshima, S.1
-
148
-
-
0032768776
-
Sensitivity and specificity of three clinical criteria for dementia with Lewy bodies in an autopsy-verified sample
-
Luis, C. A. et al. Sensitivity and specificity of three clinical criteria for dementia with Lewy bodies in an autopsy-verified sample. Int. J. Geriatr. Psychiatry 14, 526-533 (1999).
-
(1999)
Int. J. Geriatr. Psychiatry
, vol.14
, pp. 526-533
-
-
Luis, C.A.1
-
149
-
-
36248979076
-
A comparison of cerebral glucose metabolism in Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies
-
Yong, S. W., Yoon, J. K., An, Y. S. & Lee, P. H. A comparison of cerebral glucose metabolism in Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies. Eur. J. Neurol. 14, 1357-1362 (2007).
-
(2007)
Eur. J. Neurol
, vol.14
, pp. 1357-1362
-
-
Yong, S.W.1
Yoon, J.K.2
An, Y.S.3
Lee, P.H.4
-
150
-
-
0347385143
-
Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: An in vivo positron emission tomographic study
-
Bohnen, N. I. et al. Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study. Arch. Neurol. 60, 1745-1748 (2003).
-
(2003)
Arch. Neurol
, vol.60
, pp. 1745-1748
-
-
Bohnen, N.I.1
-
151
-
-
68249119247
-
Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET
-
Shimada, H. et al. Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET. Neurology 73, 273-278 (2009).
-
(2009)
Neurology
, vol.73
, pp. 273-278
-
-
Shimada, H.1
-
152
-
-
79957453213
-
Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: Which is more important?
-
Compta, Y. et al. Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important? Brain 134, 1493-1505 (2011).
-
(2011)
Brain
, vol.134
, pp. 1493-1505
-
-
Compta, Y.1
-
153
-
-
34248579291
-
Imaging beta-amyloid burden in aging and dementia
-
Rowe, C. C. et al. Imaging beta-amyloid burden in aging and dementia. Neurology 68, 1718-1725 (2007).
-
(2007)
Neurology
, vol.68
, pp. 1718-1725
-
-
Rowe, C.C.1
-
154
-
-
56749185181
-
Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography
-
Edison, P. et al. Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography. J. Neurol. Neurosurg. Psychiatry 79, 1331-1338 (2008).
-
(2008)
J. Neurol. Neurosurg. Psychiatry
, vol.79
, pp. 1331-1338
-
-
Edison, P.1
-
155
-
-
54049100454
-
Imaging amyloid deposition in Lewy body diseases
-
Gomperts, S. N. Imaging amyloid deposition in Lewy body diseases. Neurology 71, 903-910 (2008).
-
(2008)
Neurology
, vol.71
, pp. 903-910
-
-
Gomperts, S.N.1
-
156
-
-
84867510729
-
Aβ-amyloid deposition in patients with Parkinson disease at risk for development of dementia
-
Petrou, M. et al. Aβ-amyloid deposition in patients with Parkinson disease at risk for development of dementia. Neurology 79, 1161-1167 (2012).
-
(2012)
Neurology
, vol.79
, pp. 1161-1167
-
-
Petrou, M.1
-
157
-
-
37849039499
-
[11C] PIB binding in Parkinson's disease dementia
-
Maetzler, W. et al. [11C]PIB binding in Parkinson's disease dementia. Neuroimage 39, 1027-1033 (2008).
-
(2008)
Neuroimage
, vol.39
, pp. 1027-1033
-
-
Maetzler, W.1
-
158
-
-
84873647470
-
Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia
-
Gomperts, S. N. et al. Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia. Neurology 80, 85-91 (2013).
-
(2013)
Neurology
, vol.80
, pp. 85-91
-
-
Gomperts, S.N.1
-
159
-
-
0034684139
-
Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial
-
Parkinson Study Group. Pramipexole vs levodopa as initial treatment for Parkinson disease: a randomized controlled trial. JAMA 284, 1931-1938 (2000).
-
(2000)
JAMA
, vol.284
, pp. 1931-1938
-
-
-
160
-
-
19744378296
-
Levodopa and the progression of Parkinson's disease
-
The Parkinson Study Group. Levodopa and the progression of Parkinson's disease. N. Engl. J. Med. 351, 2498-2508 (2004).
-
(2004)
N. Engl. J. Med
, vol.351
, pp. 2498-2508
-
-
-
161
-
-
0037785449
-
Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study
-
Whone, A. L. et al. Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study. Ann. Neurol. 54, 93-101 (2003).
-
(2003)
Ann. Neurol
, vol.54
, pp. 93-101
-
-
Whone, A.L.1
-
162
-
-
0038249170
-
Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease
-
Gill, S. S. et al. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat. Med. 9, 589-595 (2003).
-
(2003)
Nat. Med
, vol.9
, pp. 589-595
-
-
Gill, S.S.1
-
163
-
-
0030834093
-
Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease
-
Wenning, G. K. et al. Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann. Neurol. 42, 95-107 (1997).
-
(1997)
Ann. Neurol
, vol.42
, pp. 95-107
-
-
Wenning, G.K.1
-
164
-
-
0033934144
-
Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease
-
Brundin, P. et al. Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease. Brain 123, 1380-1390 (2000).
-
(2000)
Brain
, vol.123
, pp. 1380-1390
-
-
Brundin, P.1
-
165
-
-
0028990705
-
Transplantation of fetal mesencephalic tissue in Parkinson's disease
-
Freed, C. R., Breeze, R. E. & Schneck, S. A. Transplantation of fetal mesencephalic tissue in Parkinson's disease. N. Engl. J. Med. 333, 730-731 (1995).
-
(1995)
N. Engl. J. Med
, vol.333
, pp. 730-731
-
-
Freed, C.R.1
Breeze, R.E.2
Schneck, S.A.3
-
166
-
-
0042837887
-
A Double blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease
-
Olanow, C. W. et al. A Double blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann. Neurol. 54, 403-414 (2003).
-
(2003)
Ann. Neurol
, vol.54
, pp. 403-414
-
-
Olanow, C.W.1
-
167
-
-
84870260355
-
In vivo imaging of the integration and function of nigral grafts in clinical trials
-
Politis, M. & Piccini, P. In vivo imaging of the integration and function of nigral grafts in clinical trials. Prog. Brain Res. 200, 199-220 (2012).
-
(2012)
Prog. Brain Res
, vol.200
, pp. 199-220
-
-
Politis, M.1
Piccini, P.2
-
168
-
-
0036307190
-
Dyskinesias following neural transplantation in Parkinson's disease
-
Hagell, P. et al. Dyskinesias following neural transplantation in Parkinson's disease. Nat. Neurosci. 5, 627-628 (2002).
-
(2002)
Nat. Neurosci
, vol.5
, pp. 627-628
-
-
Hagell, P.1
-
169
-
-
0036830588
-
Dyskinesia after fetal cell transplantation for parkinsonism: A PET study
-
Ma, Y. Dyskinesia after fetal cell transplantation for parkinsonism: a PET study. Ann. Neurol. 52, 628-634 (2002).
-
(2002)
Ann. Neurol
, vol.52
, pp. 628-634
-
-
Ma, Y.1
-
170
-
-
77955617871
-
Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants
-
Politis, M. et al. Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants. Sci. Transl. Med. 2, 38ra46 (2010).
-
(2010)
Sci. Transl. Med
, vol.2
-
-
Politis, M.1
-
171
-
-
78649534741
-
Dyskinesias after neural transplantation in Parkinson's disease: What do we know and what is next?
-
Politis, M. Dyskinesias after neural transplantation in Parkinson's disease: what do we know and what is next? BMC Med. 8, 80 (2010).
-
(2010)
BMC Med
, vol.8
, pp. 80
-
-
Politis, M.1
-
172
-
-
80052971467
-
Graft-induced dyskinesias in Parkinson's disease: High striatal serotonin/dopamine transporter ratio
-
Politis, M. et al. Graft-induced dyskinesias in Parkinson's disease: high striatal serotonin/dopamine transporter ratio. Mov. Disord. 26, 1997-2003 (2011).
-
(2011)
Mov. Disord
, vol.26
, pp. 1997-2003
-
-
Politis, M.1
-
173
-
-
84892394291
-
Long-term clinical outcome of fetal cell transplantation for Parkinson disease: Two case reports
-
Kefalopoulou, Z. et al. Long-term clinical outcome of fetal cell transplantation for Parkinson disease: two case reports. JAMA Neurol. 71, 83-87 (2014).
-
(2014)
JAMA Neurol
, vol.71
, pp. 83-87
-
-
Kefalopoulou, Z.1
-
174
-
-
84855291126
-
Clinical application of stem cell therapy in Parkinson's disease
-
Politis, M. & Lindvall, O. Clinical application of stem cell therapy in Parkinson's disease. BMC Med. 10, 1 (2012).
-
(2012)
BMC Med
, vol.10
, pp. 1
-
-
Politis, M.1
Lindvall, O.2
-
175
-
-
79955718250
-
Optimizing functional imaging protocols for assessing the outcome of fetal cell transplantation in Parkinson's disease
-
Politis, M. Optimizing functional imaging protocols for assessing the outcome of fetal cell transplantation in Parkinson's disease. BMC Med. 9, 50 (2011).
-
(2011)
BMC Med
, vol.9
, pp. 50
-
-
Politis, M.1
-
176
-
-
84870380368
-
PET/MRI for neurologic applications
-
Catana, C., Drzezga, A., Heiss, W. D. & Rosen, B. R. PET/MRI for neurologic applications. J. Nucl. Med. 53, 1916-1925 (2012).
-
(2012)
J. Nucl. Med
, vol.53
, pp. 1916-1925
-
-
Catana, C.1
Drzezga, A.2
Heiss, W.D.3
Rosen, B.R.4
-
177
-
-
51549120220
-
Simultaneous MR/PET imaging of the human brain: Feasibility study
-
Schlemmer, H. P. et al. Simultaneous MR/PET imaging of the human brain: feasibility study. Radiology 248, 1028-1035 (2008).
-
(2008)
Radiology
, vol.248
, pp. 1028-1035
-
-
Schlemmer, H.P.1
-
178
-
-
84884139383
-
Combined PET/MR imaging in neurology: MR-based attenuation correction implies a strong spatial bias when ignoring bone
-
Andersen, F. L. et al. Combined PET/MR imaging in neurology: MR-based attenuation correction implies a strong spatial bias when ignoring bone. Neuroimage 84, 206-216 (2014).
-
(2014)
Neuroimage
, vol.84
, pp. 206-216
-
-
Andersen, F.L.1
-
179
-
-
84870010313
-
MR-based PET attenuation correction for PET/MR imaging
-
Bezrukov, I., Mantlik, F., Schmidt, H., Schölkopf, B. & Pichler, B. J. MR-based PET attenuation correction for PET/MR imaging. Semin. Nucl. Med. 43, 45-59 (2013).
-
(2013)
Semin. Nucl. Med
, vol.43
, pp. 45-59
-
-
Bezrukov, I.1
Mantlik, F.2
Schmidt, H.3
Schölkopf, B.4
Pichler, B.J.5
-
181
-
-
84874107768
-
MRI for attenuation correction in PET: Methods and challenges
-
Wagenknecht, G., Kaiser, H. J., Mottaghy, F. M. & Herzog, H. MRI for attenuation correction in PET: methods and challenges. MAGMA 26, 99-113 (2013).
-
(2013)
MAGMA
, vol.26
, pp. 99-113
-
-
Wagenknecht, G.1
Kaiser, H.J.2
Mottaghy, F.M.3
Herzog, H.4
-
182
-
-
84884273839
-
Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls
-
Maruyama, M. et al. Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls. Neuron 79, 1094-1108 (2012).
-
(2012)
Neuron
, vol.79
, pp. 1094-1108
-
-
Maruyama, M.1
|